Key Financial Data Of Group

ONO PHARMACEUTICAL CO., LTD. - Filing #7595379

Concept 2022-04-01 to
2022-06-30
As at
2022-06-30
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of group
Business results of group
Revenue
106,722,000,000 JPY
361,361,000,000 JPY
87,363,000,000 JPY
Profit (loss) before tax
39,041,000,000 JPY
105,025,000,000 JPY
30,804,000,000 JPY
Profit (loss), attributable to owners of parent
29,477,000,000 JPY
80,519,000,000 JPY
24,074,000,000 JPY
Comprehensive income
29,697,000,000 JPY
79,606,000,000 JPY
22,696,000,000 JPY
Equity attributable to owners of parent
671,894,000,000 JPY
655,906,000,000 JPY
643,079,000,000 JPY
Total assets
764,187,000,000 JPY
739,203,000,000 JPY
741,460,000,000 JPY
Basic earnings (loss) per share
60.37
162.19
48.23
Diluted earnings (loss) per share
60.36
162.16
48.22
Ratio of owners' equity to gross assets
0.879 xbrli:pure
0.887 xbrli:pure
0.867 xbrli:pure
Cash flows from (used in) operating activities
33,078,000,000 JPY
61,829,000,000 JPY
6,756,000,000 JPY
Cash flows from (used in) investing activities
-1,320,000,000 JPY
6,038,000,000 JPY
-5,121,000,000 JPY
Cash flows from (used in) financing activities
-13,355,000,000 JPY
-60,237,000,000 JPY
-13,276,000,000 JPY
Cash and cash equivalents
87,940,000,000 JPY
69,112,000,000 JPY
49,462,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.